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Abstract 
 
The impacts of antiretroviral therapy on quality of life, mental health, labor productivity, and 
economic wellbeing for people living with HIV/AIDS in developing countries are only 
beginning to be measured. We conducted a systematic literature review to analyze the effect of 
antiretroviral therapy (ART) on these non-clinical indicators in developing countries and assess 
the state of research on these topics. Both qualitative and quantitative studies were included, as 
were peer-reviewed articles, gray literature, and conference abstracts and presentations. Findings 
are reported from 12 full-length articles, 7 abstracts, and 1 presentation (representing 16 studies). 
Compared to HIV-positive patients not yet on treatment, patients on ART reported significant 
improvements in physical, emotional and mental health and daily function. Work performance 
improved and absenteeism decreased, with the most dramatic changes occurring in the first three 
months of treatment and then leveling off. Little research has been done on the impact of ART 
on household wellbeing, with modest changes in child and family wellbeing within households 
where adults are receiving ART reported so far. Studies from developing countries have not yet 
assessed non-clinical outcomes of therapy beyond the first year; therefore, longitudinal outcomes 
are still unknown. As ART roll out extends throughout high HIV prevalence, low-resource 
countries and is sustained over years and decades, both positive and adverse non-clinical 
outcomes need to be empirically measured and qualitatively explored in order to support patient 
adherence and maximize treatment benefits.  
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antiretroviral therapy, quality of life, labor productivity, household wellbeing, developing 
countries 
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Introduction  
The clinical, immunologic, and virologic effects of antiretroviral therapy (ART) for people living 
with HIV/AIDS in resource-poor countries are well-documented. For those who adhere to 
therapy, CD4 counts can rise quickly and viral loads may drop to undetectable levels in the space 
of a year (Akileswaran, Lurie, Flanigan, & Mayer, 2005; Fairall et al., 2008; Silveira, Draschler 
Mde, Leite, Pinheiro, & da Silveira, 2002). These improved clinical markers lead to fewer 
opportunistic infections and overall reductions in AIDS-related morbidity and mortality (Fairall 
et al., 2008; Sow et al., 2007). What is less clear is the extent to which these improvements in 
clinical and laboratory outcomes translate into better physical and mental health and 
socioeconomic wellbeing for patients and their households. These non-clinical outcomes, though 
secondary to patient survival and reduced morbidity as goals of treatment provision, will become 
increasingly important as more patients initiate and remain on ART in developing countries. If 
treatment of AIDS allows patients to resume relatively normal lives—including supporting their 
families, working productively, and participating in civil society—then the long-term 
sustainability of large-scale treatment provision will be bolstered.  If, on the other hand, quality 
of life and social and economic wellbeing of ART patients are low, sustaining life-long treatment 
adherence may be even harder than expected. 
 
While the literature about quality of life and mental health outcomes of ART for HIV/AIDS in 
North America and Europe is extensive, much less is available from developing countries. Little 
research on the relationship between ART and workforce participation or labor productivity has 
been done in either developed or developing country settings. The last several years have, 
however, seen the publication of systematic reviews of research assessing the impact of ART in 
developing countries on sexual risk behavior (Crepaz et al., 2004; Kennedy, O'Reilly, Medley, & 
Sweat, 2007), treatment adherence (Akileswaran et al., 2005; Gill, Hamer, Simon, Thea, & 
Sabin, 2005; Mills et al., 2006), and patient retention (Rosen, Fox, & Gill, 2007). In this paper, 
we review reports of the effect of ART on quality of life, labor productivity, and household 
wellbeing in developing countries and assess the state of research on these topics.  
 
Methods 
Using broad search term combinations to capture a wide range of non-clinical outcomes and 
geographic regions, we conducted a systematic search of the English-language published 
literature and conference abstracts. We searched Ovid/Medline (1996-September 2008), PubMed 
(inception to September 2008), Psych Info (inception through September 2008), Web of Science 
(inception to September 2008), and Google Scholar, pairing the term antiretroviral therapy with 
each of the following: developing countries, Africa, Asia, Latin America, former Soviet 
Union/USSR, Russia, Caribbean, Brazil, China, India, Thailand, socioeconomic, mental health, 
quality of life, work productivity, household welfare, educational/school attainment. Synonyms 
(low resource countries, labor/employment, efficiency/productivity) were employed according to 
database-specific preferences, and terms were linked to medical subject headings in 
Ovid/Medline. Bibliographies of relevant articles were examined, and abstract archives from the 
International AIDS Society (IAS) conferences (2001-2008) and of the Conference on 
Retroviruses and Opportunistic Infections (1997-2007) were searched.  
 
Our inclusion criteria required that the publications describe cohorts of adult patients on ART in 
developing countries; report outcomes related to physical or mental health, labor productivity, 
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and/or household wellbeing; and compare patients on ART to patients not/not yet on ART or 
patients on ART at different points of treatment duration. Studies reporting only clinical 
outcomes or treatment-related behavior (e.g. adherence), limited to instrument validation and 
modification, or conducted in developed countries were excluded. Eligible studies were 
identified by the first author (JB) and confirmed by the second and third authors (FF and SR).  
Findings of the eligible studies were organized by topic and summarized. 
 
Figure 1. Study flow chart 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
101 excluded after first screen of 
titles and abstracts due to design 
(non-cohort), or topic (clinical, 
adherence, instrument validation,
239 potentially relevant citations identified 
through search strategy 
(excluding duplicate citations): 
221 full-text articles, 18 abstracts 
138 full text articles and abstract 
citations screened for eligibility criteria 
(developed and developing countries 
included) 
118 excluded after full-text screen due 
to country economic status (high 
resource), topic (non-clinical but not 
included in selection criteria: e.g., 
sexual behavior) 
 20 included in review 
(12 full text articles, 7 abstracts, 1 
presentation) 
1,183 potentially relevant citations 
identified through search strategy 
(including duplicate citations) 
944 excluded after first screen of 
titles and abstracts due to topic 
(clinical) 
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Results 
We reviewed 20 publications (12 full-length papers, 7 conference abstracts, 1 presentation) 
representing 16 studies selected from a total of 1,183 potential relevant citations, as illustrated in 
Figure 1. All the papers report studies conducted in sub-Saharan Africa. The conference abstracts 
and presentation extend the geographic range of the review to Asia and Latin America.  
Physical, emotional, and mental health outcomes of ART 
For the purposes of this review we use the term “quality of life” as defined by Last (2001):  “The 
degree to which persons perceive themselves able to function physically, emotionally, and 
socially.” This definition captures a broad set of domains and is not limited to any particular 
instrument or scale, but includes the wide range of measurement approaches used in the 
literature. 
Physical health 
Findings describing the impact of ART on physical, emotional, and mental health indicators are 
summarized in Table 1.  
 
Compared to HIV-positive patients not yet on treatment, patients on ART report significant 
improvements in physical health. In the Free State Province of South Africa, data has been 
collected on subjective differences in physical health for patients who have initiated ART, 
patients who have qualified for treatment but have not yet started, patients taking ART for less 
than 2 months, and patients taking ART for longer than 4 months (Booysen, Van Rensburg, 
Bachmann, Louwagie, & Fairall, 2007; Louwagie et al., 2007). Qualification for treatment alone 
appeared to boost self-perception of physical health with 55.3% of those awaiting treatment 
reporting improvements and 86.1% of patients receiving treatment reporting improvement 
(p<0.001). Self-reported improvement in physical outcomes increased over the first three months 
on treatment and then plateaued. Seventy-seven percent of patients on ART for less than 30 days 
reported overall health improvement. This proportion reached 85% for those on treatment up to 2 
months and stabilized at approximately 90% for those on treatment for 3 months or longer 
(Booysen et al., 2007). Within this cohort, Louwagie et al. (2007) report that 94% of those on 
ART reported no problems with self care compared to 83% awaiting treatment (p=0.001). 
 
Physical quality of life was also found to improve over time for ART patients in the Khayelitsha 
area of Cape Town, South Africa mobility, self-care, ability to perform usual activities, and 
pain/discomfort were assessed at baseline and after 1, 2, 3, 6, and 12 months on ART (Jelsma, 
MacLean, Hughes, Tinise, & Darder, 2005). The proportion of patients reporting no problems 
with self-care increased from 90.5% at baseline to 94.8% at 3 months, and 100% at 12 months 
(p=0.031). This pattern of rapid improvement through month 3, followed by more gradual gains, 
was similar for usual activities (baseline 75.8%, 3 months 87.6%, 12 months 94%) (p<0.01). 
Pain and discomfort, by contrast, decreased steadily over the full first year of treatment, with 
29.5% of patients reporting no problem at baseline, 53.6% at 3 months, and 73.5% at 12 months 
(p<0.01) (Jelsma et al., 2005).  
 
Improvements in physical health over the first year of treatment were also seen in rural Uganda 
where researchers found significantly improved mean MOS-HIV scores for overall physical 
health and all domains (p<0.001) between baseline and 1 year (Stangl, Wamai, Mermin, Awor, 
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& Bunnell, 2007). Overall physical summary scores (PHS) in this cohort rose from 39.2 at 
baseline to 54.2 after 1 year on ART. Role function jumped from 49.7 to 92.8; general health 
perception from 19.9 to 58.1; bodily pain from 39.4 to 75.4; vitality from 43.5 to 77.0; and 
physical function from 59.6 to 90.3. In South Africa, patients not on ART were consistently 
more likely to report body pain or headache, nausea, and fatigue (Rosen, Ketlhapile, Sanne, & 
DeSilva, 2008).  
Emotional and mental health 
ART was also associated with improved emotional and mental health for most patients. Just as 
qualification for and anticipation of receiving treatment appeared to boost perceived 
improvement in physical health among the Free State cohort, Booysen et al. (2007) found that 
65% of patients who had qualified for but not yet initiated ART reported improved emotional 
wellbeing, while 86.1% of those receiving ART reported improvement (p<0.001). Seventy-nine 
percent of patients on treatment for less than 30 days reported improved emotional wellbeing. 
The proportion of those reporting improvement rose to just over 90% in months 2 and 3 and 
leveled off at 80% after 90 days. The authors interpret this trend of a quick rise in subjective 
emotional wellbeing in the first couple of months of treatment as a “health effect” that declines 
over time as the novelty of treatment wears off and is replaced by the reality of life-long 
treatment adherence. This study also found significant differences between patients on treatment 
compared to those awaiting treatment in the following domains: satisfaction in personal life, 
satisfaction with yourself as a person, and fun in life.  
 
In all cohorts, ART was associated with reduced anxiety, depression, and dementia. In 
Khayelitsha, 85.5% of ART patients reported “no problems” with depression/anxiety after 12 
months on ART, from 68.4% at baseline (p=0.023) (Jelsma et al., 2005). In rural Uganda, Stangl 
et al. (2007) found that mental health summary scores (MHS) improved at the same pace as 
physical health scores and CD4 counts, increasing from 40.0 at baseline to 54.2 at twelve months 
(p<0.001). Depression decreased in this cohort from 46% at baseline to 8% after twelve months 
on ART (p-values not reported) (Bock et al., 2008). 
 
Finally, a small study in Kampala measuring changes in dementia over the first 6 months of 
treatment found that 61% of the 23 patients surveyed presented with mild dementia at baseline 
(Memorial Sloan Kettering dementia stage 1) (Sacktor et al., 2006). At 3 months, the proportion 
with mild dementia fell to 26% and to 4% by 6 months (p-values not reported).  
 
Table 1.  Quality of life  
 
Reference Location Study design Sample Instrument Key findings 
Addo-Atuah et 
al. (2006)  
(abstract)  
Ghana Cross-sectional, 
qualitative study  
20 PLWHA 
receiving 
ART from 4 
public clinics: 
 
35% on ART 
<1 year 
 
55% on ART 
1-2 years 
 
10% on ART 
>2 years 
Open-ended 
questionnaire 
Patient-reported outcomes of ART, 
not disaggregated by treatment 
duration 
 
Noticeable improvement in health 
status: 100% 
 
Improved function: 100% 
 
Working or capable of working: 100% 
 
Improved relationships with family and 
friends: 100% 
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Reference Location Study design Sample Instrument Key findings 
 
 
 
Adverse medication effects: 50% 
 
Difficulty accessing food: 15% 
 
Increase in hunger sensations after 
initiating ART: 100% 
Bock et al. 
(2008) 
(abstract)  
Uganda Prospective 
cohort followed 
over 12 months 
866 PLWHA 
on ART, and 
participating 
in home-
based care 
project 
evaluated at 
baseline and 
12 months 
CES-D Patient-reported depression and 
daily function over 12 months 
 
Baseline: 402 (46%) patients reported 
depression; 435 (50%) reported 
functional limitations 
 
12 months: prevalence of depression 
dropped to 8%; prevalence of functional 
impairment dropped to 7% 
 
Booysen et al. 
(2007)  
Free State 
Province, 
South 
Africa 
Baseline report 
of prospective 
cohort study  
Index: 268 
ART patients  
 
Reference: 
103 patients 
awaiting ART 
 
 
South Africa 
Quality of Life 
Trends domains 
 
Open-ended 
questions to 
capture self-
reported 
improvements 
 
Patient-reported changes in 
subjective physical and emotional 
well being: patients qualified for but 
not yet on ART and patients on 
treatment from <20 days to >90 days 
Improvements in physical health since 
completing drug readiness training: 
patients on ART 86.1%; awaiting ART 
55.3% (p<0.001) 
Improvements in emotional well-being 
since completing drug readiness 
training: patients on ART 86.1%; 
awaiting ART 80.2% (p<0.001) 
Satisfaction in personal life: patients on 
ART 79.9%; awaiting ART 74.7% 
(p=0.026) 
Satisfaction with yourself as a person: 
patients on ART 92.1%; awaiting ART 
85.2% (p=0.023) 
Fun in life: patients on ART 74.9%; 
awaiting ART 61.3 (p=0.005) 
Erhabor et al. 
(2006)  
(abstract) 
Nigeria Prospective 
cohort followed 
for 48 weeks 
Unclear Questionnaire on 
adverse clinical 
events, general 
health 
perception, and 
emotional effect 
of pill burden  
Patient-reported changes between 
ART initiation (baseline) and 48 
weeks on therapy 
 
Current positive health perception: 
baseline 53%; 48 weeks 87.3% 
 
Emotional quality of life declined due to 
ART-related overweight and truncal 
obesity, adverse clinical events, Steven 
Johnson’s syndrome, and high pill 
burden. 
Hoosen et al. 
(2006) 
(abstract) 
Sub-
Saharan 
Africa 
Prospective 
cohort followed 
for 6 months 
23 PLWHA 
with Kaposi’s 
sarcoma 
enrolled in 
clinical trial 
EORTC QoL 
questionnaire 
(QLQ C30) 
Patients with Kaposi Sarcoma report 
on QoL improvements 6 months after 
starting treatment. 
 
Improved function: cognitive (p=0.003) 
and social (p=0.046)  
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Reference Location Study design Sample Instrument Key findings 
Jelsma et al. 
(2005)  
Cape Town, 
South 
Africa 
Prospective 
cohort study 
measuring QoL 
at 3, 6, and 12 
months after 
ART initiation 
117 ART 
patients 
EQ-5D 
 
 
 
 
 
 
 
 
 
 
 
 
 
Visual Analog 
Score (VAS) 
Proportion of cohort reporting no 
problems in domain at baseline and 
after 12 months on ART 
Self-care: baseline 90.5%; 12 months 
100.0% (p=0.031) 
Usual activities:  baseline 75.8%;12 
months 94.0% (p<0.01) 
Pain/discomfort: baseline 29.5%; 12 
months 73.5% (p<0.01) 
Anxiety/depression: baseline: 68.4%; 12 
months 85.5% (p=0.023) 
Mean VAS* at baseline and after 12 
months on ART 
Baseline: 61.7 (SD 22.7) 
12 months: 76.1 (SD 18.5) 
*Visual Analogue Scale: 0-100 (0=dead, 
100 perfect health) (Shmueli, 2005) 
Louwagie et al. 
(2007)  
Free State 
Province, 
South 
Africa 
Cross-sectional 
study measuring 
HRQoL in 
PLWHA 
receiving or 
awaiting ART 
Index: 268 
patients on 
ART 
 
Reference: 
103 patients 
awaiting ART 
EQ-5D 
 
 
 
 
 
 
 
 
 
 
 
VAS scores 
Proportion of cohort reporting no 
problems 
 
Mobility: index 81%; reference 71% 
(p=0.026) 
 
Self care: index 94%; reference 83% 
(p=0.001) 
 
Pain/discomfort:  index 60%; reference 
44% (p=0.022) 
 
Mean VAS for patients receiving ART 
and patients awaiting ART 
 
Receiving ART: 66 (SD 20) 
 
Awaiting ART: 62 (SD 23) 
Rosen et al. 
(2008)  
South 
Africa 
Baseline report 
from longitudinal 
cohort study 
measuring early 
impact of ART 
on functional 
impairment, 
symptom 
prevalence, and 
employment at 3 
clinics 
427 patients 
on ART for 
1-6 months 
(208  on ART 
1-3 months, 
219 on ART 
3-6 months 
 
453 patients 
receiving 
pre-ART 
care 
Questions from 
South African 
Census, MOS-
HIV, and the 
WHO 
Performance 
Questionnaire 
 
Differences in function prior to ART 
up to 6 months 
 
Mean full days of functional impairment:  
Pre-ART 1.61 (SD 2.01) 
ART 1-6 months 0.87 (SD 1.65) 
(p<0.001) 
 
 
Sacktor et al. 
(2006)  
Kampala, 
Uganda 
Prospective 
cohort study 
measuring QoL 
at baseline, 3, 
and 6 months 
after treatment 
initiation 
23 patients 
from the 
Infectious 
Disease 
Clinic at 
Mulago 
Hospital 
Memorial Sloan 
Kettering 
Dementia Scale 
 
 
 
 
 
Karnofsky 
Functional 
Performance 
Scale 
 
 
 
 
Changes in dementia at baseline, 3 
and 6 months 
 
Mild dementia: (p=0.046) 
Baseline: 61%   
3 months: 26%  
6 months: 4%  
 
Mean Karnofsky Score 
 
Baseline: 65 
3 months: 75*  
6 months: 80* 
 
*75 indicates ability to care for self but 
not to work or conduct normal activity 
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Reference Location Study design Sample Instrument Key findings 
 
 
 
 
*80 indicates capability of normal 
activity but disease signs/symptoms are 
discernable 
Stangl et al. 
(2007)  
Rural 
Uganda 
Prospective 
cohort  
measuring 
predictors of 
QoL over first 12 
months on ART 
947 patients 
participating 
in 3 year 
Home-Based 
AIDS Care 
Project 
MOS-HIV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CES-D  
MOS-HIV mean scores at baseline 
and 12 months (p<0.001 for all 
outcomes) 
Role function: baseline 49.7; 12 months 
92.8  
General health perceptions: baseline 
19.9; 12 months 58.1 
Mental health: baseline 58.1; 12 months 
81.6 
Physical health summary score:  
baseline 39.2; 12 months 54.2  
Mental health summary score: baseline 
40.0; 12 months 54.2  
Proportion of patients with CES-D 
scores >16* at baseline and 12 
months (p values not given) 
Baseline: 64.1 
12 months: 54.7 
*CES-D score of >16 indicates 
depression 
 
Labor productivity 
Labor-related outcomes (summarized in Table 2) include HIV-related absenteeism and 
retirement, work performance or productivity, and health-related impairment (“impaired 
presenteeism”) while on the job.   
Absenteeism/presenteeism 
Absenteeism appears to decrease significantly over the first year on ART. Looking at company 
work performance records of HIV-positive employees of the Electricity Company of Cote 
d’Ivoire, Eholie and Nolan (2003) found a 94% drop in days of work missed over 3 years. Mean 
sick leave time decreased from 3.5 months 1 year prior to treatment initiation to 0.24 months 
after one year of ART and 0.16 after 2 years bringing them close to the 0.14 average sick leave 
among all workers (Eholie & Nolan, 2003).  
 
Larson et al. (2008) used human resource records from a Kenyan tea plantation to track worker 
presenteeism or number of days per month spent plucking tea 24 months prior to starting 
treatment through the first 12 months. Comparing company data on 59 employees (33 women 
and 26 men) receiving ART matched to 1992 workers from the same gangs, they found that 24 
months prior to initiating treatment, male intervention and comparison workers plucked tea 
approximately the same number of days. At treatment initiation, intervention men plucked tea 
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10.81 fewer days than comparison men (p=0.00), and by the fourth month of treatment had 
rebounded to the point where differences in days spent plucking between the two groups were no 
longer significant (Larson et al., 2008).  
 
Female tea pluckers did not rebound as successfully as their male counterparts. Women in the 
intervention group plucked tea significantly fewer days than female comparisons in each of the 
12 months prior to treatment as well as in the months after starting ART (Larson et al., 2008). At 
treatment initiation, intervention women plucked tea 14.82 fewer days than comparison women 
(p=0.00). After twelve months of treatment, that difference had fallen to 6.36 fewer days 
plucking than comparison women (p=0.00). Despite this positive trend, intervention women still 
plucked approximately 30% fewer days than comparison women by the end of the first year on 
treatment. 
 
In Botswana, no difference in absenteeism was found between diamond mind employees who 
ultimately enrolled in the company’s AIDS treatment program and the workforce as a whole in 
the 5 years to 15 months prior to treatment, but absenteeism rose sharply in the last year before 
treatment initiation, to a high of 5 days absent in the month before initiation.  Once treatment 
started, absenteeism fell equally sharply, so that after an average of 6 months on treatment, 
enrolled workers’ attendance returned to a pattern similar to the rest of the workforce 
(Habyarimana, Mbakile, & Pop-Eleches, 2008).  
 
In South Africa, a similar pattern was discerned among Anglo American mining group 
employees receiving ART; 7.5 days of work were missed per month at treatment initiation, 2.9 
days after 6 months, and 2.1 after 18 months (comparison data not provided) (Charalambous et 
al., 2007; Muirhead et al., 2006). Also in South Africa, workers on ART from 1-2 months 
reported a significant difference in mean days of work missed in the previous month (4.2), 
compared to those on ART for 3-6 months (1.3) (Rosen et al., 2008). In India, significant 
improvements in ability to work and hours worked occurred in the first 6 months of treatment 
and were sustained over the following year, with no significant changes at 12 or 18 months 
(Thirumurthy et al., 2008). 
 
Thirumurthy, Graff Ziven, and Goldstein (2005) measured labor force participation in Kenya in 
266 HIV-positive adults on ART against a random sample of 503 comparisons in two interviews 
over a period of 6 months, categorizing patients as “on ART for 100 days or less” and on “ART 
100 days or more.” They found that patients on treatment for longer than 100 days at baseline 
worked more than those just starting treatment, but significant improvement in ability to work 
was found in those on treatment for 3 months or less. Patients who had been on ART for less 
than 100 days at baseline participated in the labor force 28.2% less than comparisons at that 
point in time and 12.8% less than comparisons at month 6. This gap in labor force participation 
narrowed for patients on ART for 100 days or longer who worked 7.9% less than comparisons 
(Thirumurthy, Graff Zivin, & Goldstein, 2005).  
Work performance 
Work productivity and performance appear to improve as a result of ART. Prior to beginning 
treatment, only 12.5% of Cote d’Ivoire Electricity Company workers were able to perform full 
Nonclinical outcomes of ART in developing countries HDDP11 
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duties (Eholie & Nolan, 2003). After 1 year on ART this proportion increased to 84% and to 
91% by 2 years (p-values not reported).  
 
In Kenya, productivity differences between HIV-positive male employees and matched 
comparisons were significant in months 20, 7, 4, and 2 prior to treatment initiation and during 
the first month of treatment. Once on treatment, there was no significant difference in the amount 
of tea leaf plucked by male intervention workers. Intervention women plucked significantly less 
tea 10 out of the total 37 months analyzed compared to intervention men (5/37 months). The data 
do not reveal the reasons for the differences between the work patterns for HIV-positive men and 
women. The researchers hypothesize that women may experience more HIV-related sickness 
both before and after treatment initiation and as a result request more days of light duty. Women 
known to be HIV-positive, they speculate, may simply be assigned to light duty by the clinical 
officers overseeing their care (Larson et al., 2008). 
 
Work performance trends among HIV-positive employees have also been measured in terms of 
functional impairment. In South Africa, Rosen et al. (2008) report that patients not on ART were 
almost twice as likely to report whole or partial days of impairment in the previous week. 
Employees not on ART reported 1.61 mean full days of functional impairment compared to 0.87 
days among those who had been on ART for 1-6 months (p<0.0001). 
 
The most dramatic improvements in ability to work and performance were reported in the first 3 
months of treatment. In Kenya, Thirumurthy et al. (2005) found that the largest increases in labor 
force participation were reported by those who had been on treatment 100 days or less at 
baseline. Six months later (6-9 months after treatment initiation) their labor force participation 
increased by 16.7% and hours worked increased by 6.934 per week. Workers who had been on ART 
longer than 100 days at baseline had much smaller increases in work participation (1.3%) and 
hours worked (0.992) (Thirumurthy et al., 2005).  
 
Table 2. Labor productivity (workplace) 
 
Reference Location Design Sample Key findings 
Eholie and 
Nolan (2003)  
Cote d’Ivoire Prospective cohort study 
measuring socioeconomic 
impact of private enterprise 
ART program over 3 years 
HIV+ employees of Electricity 
Company of Cote d’Ivoire  
Counts of HIV+ employees, 
employees on ART, HIV-
related deaths, proportion 
able to perform full duties, 
and mean sick leave (p-
values not reported) 
 
1999 (n=3459): 96 HIV+ 
workers; 0 on ART; 16 HIV-
related deaths; 12.5% of 
workers able to perform full 
duties; mean 3.5 months sick 
leave 
 
2000 (n=3482): 94 HIV+ 
workers; 62 on ART; 9 HIV-
related deaths; 84% workers 
able to perform full duties; 
mean 0.24 months sick leave 
 
2001 (n=3728): 101 HIV+ 
workers; 74 on ART; 5 HIV-
related deaths; 91% of 
workers able to perform full 
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duties; mean 0.16 months 
sick leave 
Habyarimana et 
al. (2008)  
Botswana Retrospective cohort 
assessing impact of ART on 
worker absenteeism up to 
five years after ART initiation 
441 workers from 2 
Debswana Diamond 
Company mines receiving 
ART 
 
Comparison population of 
approximately 7,000 workers 
not enrolled in treatment 
program (HIV status 
unknown) 
 
 
Absenteeism in days/month 
for employees on ART v. 
rest of workforce 
 
5 years to 15 months before 
ART initiation:  no difference 
between enrolled workers and 
rest of workforce 
 
Last year before initiation:  
absenteeism of enrolled 
workers increases sharply to 
a peak of 5 days/month in last 
month 
 
First 6 months after initiation:  
absenteeism declines sharply 
 
7 months-4 years after 
initiation:  no difference 
between enrolled workers and 
rest of workforce  
Iro et al. (2008) 
(abstract) 
Nigeria Prospective cohort 
assessing effect of ART on 
work productivity 
124 HIV+ patients on ART 
 
111 HIV+ patients not yet on 
ART 
 
124 HIV- or unknown 
serostatus individuals 
Mean work days lost 
(p<0.05): 
 
HIV+ on ART: M=1.06 (SD 
1.516) 
 
HIV+ not on ART: M=4.16 
(SD 3.282) 
 
HIV- or unknown serostatus: 
M=0.05 (SD 0.366) 
 
Mean restricted activity 
days and bed disability 
days: 
Differences between HIV+ 
patients on ART reported to 
be significantly fewer than 
patients not on ART. Specific 
numbers not reported. 
Larson et al. 
(2008)  
Kericho 
District, 
Kenya 
Retrospective cohort 
assessing early effects of 
ART on tea plucker 
presenteelism and 
productivity over 37 months 
59 intervention tea plantation 
employees on ART 
 
1992 comparison workers 
matched by work units (HIV 
status unknown) 
Mean days spent plucking 
24 months preceeding and 
12 months after ART 
initiation 
 
24 months prior to ART: 
intervention 16.41; 
comparison 17.05 (p=0.59) 
 
1 month prior to ART: 
intervention 13.68; 
comparison 18.77 (p<0.00) 
 
12 months on ART: 
intervention 14.38; 
comparison 17.05 (p=0.04) 
 
Larson et al. 
(2008)  
Kericho 
District, 
Kenya 
Retrospective cohort 
assessing early effects of 
ART on tea plucker 
productivity and 
presenteeism over 37 
months 
59 intervention tea plantation 
workers on ART 
 
1992 comparison workers 
matched by work units (HIV 
status unknown) 
Gender disaggregated 
mean days plucking and 
mean kgs of tea leaf 
harvested per month  
 
24 months prior to ART:  
Mean days plucking: 
male intervention 17.35; male 
comparison 16.90 (p=0.85); 
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female intervention 15.67; 
female comparison 18.12 
(p=0.09) 
 
Mean kgs of tea leaf plucked: 
male intervention 37.97; male 
comparison 42.23 (p=0.11); 
female intervention 32.44; 
female comparison 38.53 
(p=0.02) 
 
1 month prior to ART:  
Mean days plucking: 
male intervention 15.85; male 
comparison 18.20 (p=0.27) 
female intervention 11.97; 
female reference 19.85 
(p=0.000) 
 
Mean kgs of tea leaf plucked: 
male intervention 41.26; male 
comparison 44.59 (p=0.33); 
female intervention 29.59; 
female comparison 32.96 
(p=0.16) 
 
12 months on ART: 
Mean days plucking: 
male intervention 14.96; male 
comparison 15.99 (p=0.67); 
female intervention 13.91; 
female comparison 20.26 
(p=0.00) 
 
Mean kgs of tea leaf plucked: 
male intervention 35.37; male 
comparison 36.42 (p=0.76); 
female intervention 28.67; 
female comparison 34.15 
(p=0.02) 
Muirhead et al. 
(2006) (abstract) 
South Africa Prospective cohort over 3 
years 
2400 employees of large 
South African employer 
Mean worker absence over 
18 months on ART 
 
Immediately prior to ART 
initiation: 7.5 days/month  
 
6 months on ART: 2.9 
days/month  
 
12 months: 2.2 days/month 
 
18 months: 2.1 days/month 
Rosen et al. 
(2008)  
South Africa Baseline report from 
longitudinal cohort study 
measuring early impact of 
ART on functional 
impairment, symptom 
prevalence, and 
employment at 3 clinics 
427 patients on ART for 1-6 
months (208  on ART 1-3 
months, 219 on ART 3-6 
months 
 
453 patients receiving pre-
ART care 
Differences in absenteeism 
prior to ART up to 6 months 
 
Mean days absent due to 
health in previous month:  
Pre-ART 3.1 (SD 7.5); 
ART 1-6 months 2.7 (SD 7.7) 
(p=0.0108) 
 
ART 1-3 months 4.2 (SD 9.8) 
ART 3-6 months 1.3 (SD 5.0) 
(p=0.0353) 
Sgombich et al. 
(2006)  
(abstract) 
Chile Prospective cohort Baseline: 799 PLWHA 
receiving ART from 8 public 
hospitals 
28 months: 512 PLWHA 
followed up 
HIV+ worker absenteeism 
over 28 months on ART 
 
Days absent decreased from 
78 days/year to 52 days/year 
(p=0.0372) between baseline 
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and 28 months 
Thirumurthy et 
al. (2005)  
Kosirai 
District, 
Kenya 
Prospective cohort 
assessing labor supply of 
ART patients at baseline 
and 6 months 
191 ART patients and 1286 
randomly sampled 
comparison adults 
 
 
 
 
Labor force participation 
and hours worked in last 
week at baseline (Round 1) 
and at a 6 months (Round 2) 
 
Baseline: Illness reported as 
reason for not working in past 
week:  
ARV patients 85% 
Comparisons 8% 
 
Patients on ART for less than 
100 days at baseline: worked 
28.2% less than comparisons 
in Round 1 and 12.8% less in 
Round 2 (p=0.01);  
worked 15.785 less hours 
than comparisons at baseline 
and 9.916 fewer hours in 
Round 2 (p=0.01) 
 
Patients on ART for more 
than 100 days at baseline: 
worked 7.9% less than 
comparisons in Round 1 and 
7.1% less in Round 2 
(p=0.05);  
worked 8.2 days less than 
comparisons at baseline and 
8.133 less in Round 2 
(p=0.01) 
Thirumurthy et 
al. (2008)  
(conference 
presentation) 
Tamil Nadu, 
India 
Prospective cohort following 
patients on ART over 18 
months 
Patients enrolled in Tamil 
Nadu Family Care 
Continuum Program 
 
515 patients receiving ART 
 
804 comparison patients 
(HIV+ but not yet eligible for 
ART) 
Changes in labor force 
participation, hours worked 
in past week, and income in 
past 30 days  
 
Baseline:  
31% worked in past week; 
12.7 hours worked in past 
week; 
710.7 rupees earned in past 
30 days 
 
6 months on ART; 
53% worked in past week 
25.5 hours worked in last 
week; 
1135.3 rupees earned in past 
30 days 
 
12 months on ART: 
60.5 hours worked in past 
29.93 hours worked in past 
week; 
1285.3 rupees earned in past 
30 days 
 
18 months on ART 
58.8 hours worked in past 
week 
26.74 hours worked in last 
week; 
1461.6 rupees earned in past 
30 days 
 
Differences between baseline 
and subsequent months 
significant (p=0.01) 
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Differences between months 
6, 12, and 18 not significant 
 
Findings for comparison 
group not provided 
 
 
Household wellbeing 
Data describing the association between an adult’s improved ability to work and child labor, 
school enrollment, family nutrition (summarized in Table 3) come from cohorts in Kenya and 
India (Graff Zivin, Thirumurthy, & Goldstein, 2007; H.  Thirumurthy et al., 2005; Thirumurthy 
et al., 2008). In households where the adult on ART had been on treatment for more than 100 
days at baseline, boys age 8-12 were found to engage in work outside the house 22.7% (8.644 
hours) less 6 months later (Thirumurthy et al., 2005). In households with 2 adult ART patients, 
labor participation dropped 79.2% (p=0.01) for boys age 8-12 after adults started therapy and 
26.7% (p=0.10) for boys age 12-18. However, girls of any age and children in households with 
only 1 adult on treatment did not experience significant changes. Families with an adult on ART 
also borrowed significantly less money after 6 months on treatment (Thirumurthy et al., 2008).  
Households reported increased consumption of bananas, carrots, beans, and potatoes, within the 
first 6 months of treatment (Thirumurthy et al., 2008). Wasting in children under age 5 decreased 
from 12% at baseline to 5% after an adult caretaker had been on ART for 6 months (Graff Zivin 
et al., 2007). At baseline, children in households with an adult on ART had a significantly higher 
prevalence of wasting compared to children in a random sample of non-patient households, but 
this difference virtually disappeared after 6 months on ART.  
 
Finally, treatment of an adult caretaker was also associated with differences in school attendance 
among children. In the 6 months between baseline and follow up, school enrollment did not 
change significantly for children living in ART households. But, for children living in 
households where an adult had just started treatment, the number of hours attended increased by 
6.393 hours per week (21%) (Graff Zivin et al., 2007).  
 
Table 3.  Household wellbeing 
 
Reference Location Design Sample Key findings 
Graff Zivin et al. 
(2007)  
Kosirai 
Division, 
Kenya 
Prospective cohort measuring 
impact of ART on schooling 
and nutrition of children within 
household 
ART households: 128 
children  
 
Random sample of 
households: 352 children  
Wasting in children under 5 
at baseline and 6 months in 
ARTand random sample 
households  
 
Baseline: ART households 
12%; Random sample 4% 
(p=0.03) 
 
6 months: ART households 
5%; Random sample 2% 
(p=0.17) 
 
Increases in number of 
hours child living with an 
adult on ART attended 
school 6 months after 
baseline 
 
<100 days (p=0.05):  
All children 6.393;  
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 Boys 8.673;  
Girls 6.513  
 
 >100 days: 
All children 1.893; (not 
statistically significant) 
Boys 4.902 (p=0.10);  
Girls –1.035 (not statistically 
significant) 
Thirumurthy et 
al. (2005)  
Kosirai 
Division, 
Kenya 
Retrospective cohort 
assessing labor supply of ART 
patients and labor supply of 
other adults and children in 
household at baseline and 6 
months 
Index households: 266 with 
at least ART patient 
 
Comparison households: 503 
randomly sampled from 
district 
Proportion of children who 
worked outside the home in 
previous week in ART and 
comparison households at 
baseline and 6 months  
 
Baseline: 
Boys 8-18: index 74%; 
comparison 78% (p=0.24) 
 
Girls 8-18: index 63%; 
comparison 74% (p=0.02) 
 
6 months:  
Boys 8-12 living with adults on 
ART >100 days worked 22.7 
percent less than in Round 1 
(p=0.05) 
 
Labor differences between 
rounds were not significant for 
older boys or girls of any age. 
 
Thirumurthy et 
al. (2008)  
(conference 
presentation) 
Tamil 
Nadu, India 
Prospective cohort following 
patients on ART over 18 
months 
Patients enrolled in Tamil 
Nadu Family Care 
Continuum Program 
 
515 patients receiving ART 
 
804 comparison patients 
(HIV+ but not yet eligible for 
ART) 
Proportion of families with 
an adult on ART consuming 
food items (estimates, p 
values not reported) 
 
Baseline: 
Bananas 70% 
Beans 70% 
Carrots 78% 
Potatoes 77% 
 
6 months: 
Bananas79% 
Beans 82% 
Carrots 85% 
Potatoes 83% 
 
12 months: 
Bananas 83% 
Beans 82% 
Carrots 85% 
Potatoes 85% 
 
18 months: 
Bananas 83% 
Beans 83% 
Carrots 86% 
Potatoes 85% 
 
Rupees borrowed by 
families with adult on ART 
(estimates, p values not 
reported) 
 
Baseline: 11,800 rupees 
6 months: 5,000 rupees 
12 months: 5,500 rupees 
18 months: 5,500 rupees 
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Findings for comparison 
group not provided 
 
 
Discussion 
For the most part, research on the non-clinical outcomes of antiretroviral therapy in developed, 
transitional, and developing countries presents positive findings. Those patients for whom 
treatment is successful, who are able to adhere to drug regimens over time, report improvements 
in physical, emotional, and mental health, and to some extent their ability to work outside the 
home, as well as more general improvements in household wellbeing. For those able to remain 
employed while ill and through treatment initiation, the ability to work improved within 6 
months, and levels of absenteeism decreased rapidly.  
 
Maintaining high levels of adherence over the possible decades that ART can extend life will 
remain challenging for both patients and those providing therapy. The difficulty of sustaining 
improvements over long periods of time found in developed countries is likely to influence 
quality of life and adherence in low resource contexts as well (Burgoyne & Renwick, 2004; 
Burgoyne & Tan, 2008; Gill et al., 2005). Based on the findings we reviewed, physical and 
mental health improvements seem to stabilize after 6 months. As years on treatment accumulate, 
researchers will need to track the transition from the buoyancy of treatment optimism to the 
doldrums of treatment fatigue when the promises of ART are checked by the reality of life with 
an infectious, sexually transmitted, chronic disease (Addo-Atuah et al., 2006; Carr, 2002; Gray & 
Berger, 2007; Kumarasamy et al., 2008; Russell et al., 2007). 
 
Our review has several limitations. Because we set out to provide a broad overview of non-
clinical research, we have not probed the methods or findings of the studies reported in depth. 
Finally, the relatively small number of studies found and reviewed, most of which are limited to 
sub-Saharan Africa, indicates the overall limitations within the non-clinical outcomes field of 
inquiry. Of equal concern is the relative lack of attention to patients lost to follow up as a result 
of treatment discontinuation, possibly resulting from adverse outcomes (Rosen, Fox, & Gill, 
2007). In terms of the overall state of research on the topic of nonclinical outcomes of ART, the 
extent to which publication bias is a factor limiting the reporting of adverse outcomes is 
unknown.  
 
Future research priorities should include continued longitudinal research of ART outcomes 
beyond 12 months; qualitative exploration of experiences and perceptions of ART patients 
regarding drug side-effects, continued impairment, treatment fatigue, the so-called “Lazarus 
phenomenon” resulting from the ability of ART to pull patients back from the brink of death 
after they have made peace with that fate (Brashers et al., 1999; Thompson & Thompson, 2003), 
the economic wellbeing of families and households, and more. Full reporting of both positive 
and negative treatment outcomes should be prioritized in order to understand the specific 
challenges faced by ART patients in developing countries, support adherence for life, and assist 
them in maximizing treatment benefits. 
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